Thao Nguyen, MD
Internal Medicine · Seattle, WANPI 1255560017
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 447 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 447 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$1K
- AbbVie$1K
- Lilly USA, LLC$1K
- Sun Pharmaceutical Industries Inc.$932
- Novartis$887
- UCB, Inc.$816
- plus $4K from 23 others
What the payments were for
- Travel & lodging$50%
- Food & beverage$10,01598%
- Education$1772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 32 | $1,148 |
| AbbVie(2 entities) | 51 | $1,108 |
| Lilly USA, LLC | 43 | $1,011 |
| Sun Pharmaceutical Industries Inc. | 30 | $932 |
| Novartis | 65 | $887 |
| UCB, Inc. | 33 | $816 |
| Sanofi | 18 | $425 |
| Almirall LLC | 19 | $401 |
| Johnson & Johnson | 19 | $388 |
| Regeneron Healthcare Solutions, Inc. | 11 | $385 |
| Amgen | 20 | $381 |
| Arcutis Biotherapeutics, Inc. | 10 | $357 |
| Dermavant Sciences, Inc. | 18 | $318 |
| Incyte Corporation | 12 | $227 |
| Pfizer | 6 | $207 |
| E.r. Squibb & Sons, L.L.C. | 12 | $191 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $188 |
| LEO Pharma Inc. | 8 | $175 |
| Bristol Myers Squibb | 7 | $139 |
| Boston Scientific | 1 | $109 |
| Genentech USA, Inc. | 4 | $75 |
| Boehringer Ingelheim | 4 | $75 |
| Sebela Pharmaceuticals Inc. | 5 | $73 |
| Dermira, Inc. | 3 | $49 |
| VYNE Pharmaceuticals Inc. | 2 | $43 |
| DUSA Pharmaceuticals, Inc. | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| Promius Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ODOMZO$276
- EPIDUO FORTE$274
- AKLIEF$143
- ORACEA$140
- SOOLANTRA$140
- Rinvoq$121
- DUPIXENT$115
- EUCRISA$109
- GENERAL - BILIARY DEVICES$109
How this compares
$10,197 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tretinoin | 84 | $4,565 |
| Fluorouracil | 63 | $4,446 |
| Clobetasol Propionate | 113 | $4,314 |
| Ketoconazole | 264 | $3,430 |
| Triamcinolone Acetonide | 233 | $2,720 |
| Ciclopirox | 99 | $2,113 |
| Clindamycin Phosphate | 66 | $1,669 |
| Econazole Nitrate | 46 | $1,257 |
| Doxycycline Hyclate | 76 | $1,163 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 16 | $739 |
| Mupirocin | 106 | $654 |
| Gentamicin Sulfate | 21 | $653 |
| Nystatin | 30 | $639 |
| Imiquimod | 18 | $499 |
| Hydrocortisone | 111 | $497 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Seattle
- Peter ShalitSeattle$1M
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Kevin ChungSeattle$35K
- David DaleSeattle$35K
- Catherine BenzigerSeattle$13K
- Christopher DoddSeattle$12K
- Dedra BuchwaldSeattle$11K
- James FloydSeattle$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.